Clinical Trials for Highlightll Pharmaceutical

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Highlightll Pharmaceutical

Clinical Trials (4)

NCT06997484
First-in-Human Single and Multiple Dose of HL-400
PHASE1Recruiting
54 participants
Started: Apr 25, 2025 · Completed: Feb 27, 2026
1 condition1 sponsor1 location
NCT06887127
A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
PHASE3Recruiting
350 participants
Started: Mar 10, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06396026
A Study of Efficacy and Safety of TLL-018 in CSU Participants
PHASE3Recruiting
436 participants
Started: Dec 24, 2024 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT06020144
A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
PHASE3Recruiting
450 participants
Started: Nov 15, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location